Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene

Archives of Medical Research

Volumn 30, Issue 6, 1999, Pages 510-513

  Polak, Michel ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Thyroid adenoma; Thyroid autonomy; TSH receptor gene mutations

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN; THYROTROPIN RECEPTOR;

GENE MUTATION; HUMAN; PHENOTYPE; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; THYROID ADENOMA; THYROID TUMOR;

ADENOMA; ANIMALS; HUMANS; HYPERTHYROIDISM; MUTATION; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS;

EID: 0033394739     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(99)00067-3     Document Type: Review

References (38)

1. Parmentier M., Libert F., Maenhaut C., Lefort A., Gerard C., Perret J., Van Sande J., Dumont J.E., Vassart G. Molecular cloning of the thyrotropin receptor. Science. 246:1989;1620.
2. Vassart G., Dumont J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev. 13:1992;596.
3. Gross B., Misrahi M., Sar S., Milgrom E. Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun. 177:1991;679.
4. Tonacchera M., Van Sande J., Cetani F., Swillens S., Schvartz C., Winiszewski P., Portmann L., Dumont J.E., Vassart G., Parma J. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 81:1996;547.
5. Dremier S., Coppee F., Delange F., Vassart G., Dumont J.E., Van Sande J. Thyroid autonomy. mechanism and clinical effects. Clinical review 84 J Clin Endocrinol Metab. 12:1996;4187.
6. Paschke R., Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med. 337:1997;1675.
7. Wess J. G-protein-coupled receptors. molecular mechanisms involved in receptor activation and selectivity of G-protein recognition FASEB J. 11:1997;346.
8. Bodenner D.L., Lash R.W. Thyroid disease mediated by molecular defects in cell surface and nuclear receptors. Am J Med. 105:1998;524.
9. Kopp P., Van Sande J., Parma J., Duprez L., Gerber H., Joss E., Jameson J.L., Dumont J.E., Vassart G. Congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. N Engl J Med. 332:1995;150.
10. De Roux N., Polak M., Couet J., Leger J., Czernichow P., Milgrom E., Misrahi M. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab. 81:1996;2023.
11. Polak M. Activating mutations of the thyrotropin receptor. a short review with emphasis on some pediatric aspects Eur J Endocrinol. 138:1998;353.
12. Laurent E., Mockel J., Van Sande J., Graff I., Dumont J.E. Dual activation by thyrotropin of the phospholipase C and cyclic AMP cascades in human thyroid. Mol Cell Endocrinol. 52:1987;273.
13. Van Sande J., Raspe E., Perret J., Lejune C., Maenhaut C., Vassart G., Dumont J.E. Thyrotropin activates both the cAMP and the PIP2 cascades in CHO-K1 cells expressing the human cDNA of thyrotropin receptor. Mol Cell Endocrinol. 74:1990;R1.
14. Allgeier A., Offermans S., Van Sande J., Spicher K., Schultz G., Dumont J.E. The human thyrotropin receptor activates G-protein Gs and Gq11. J Biol Chem. 269:1994;13733.
15. 2+ cascade in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab. 79:1994;152.
16. Duprez L., Parma J., Van Sande J., Rodien P., Dumont J.E., Vassart G., Abramowicz M. TSH receptor mutations and thyroid disease. Trends Endocrinol Metab. 9:1998;133.
17. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J.E., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:1993;649.
18. Porcellini A., Ciullo I., Laviola L., Amabile G., Fenzi G., Avvedimento V.E. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 79:1994;657.
19. Paschke R., Tonacchera M., Van Sande J., Parma J., Vassart G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1994;1785.
20. Tonacchera M., Van Sande J., Parma J., Duprez L., Cetani F., Costagliola S., Dumont J.E., Vassart G. TSH receptor and disease. Clin Endocrinol. 44:1996;621.
21. Derwahl M. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas. a note of caution J Clin Endocrinol Metab. 81:1996;2783.
22. + cascades Mol Endocrinol. 9:1995;725.
23. Russo D., Arturi F., Suarez H.G., Schlumberger M., Du Villard J.A., Crocetti U., Filetti S. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 81:1996;1548.
24. Parma J., Duprez L., Van Sande J., Hermans J., Rocmans P., Van Vliet G., Costagliola Rodien P., Dumont J.E., Vassart G. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs-alpha gene as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 82:1997;2695.
25. Hamburger J.I. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab. 50:1980;1089.
26. Laurberg P., Pedersen K.M., Vestergaard H., Sigurdsson G. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake areas vs. high incidence of Graves' disease in the young in a high iodine intake area. comparative surveys of thyrotoxicosis epidemiology in East-Jutland, Denmark and Iceland J Intern Med. 229:1991;415.
27. Fuhrer D., Holzapfel H.P., Wenerow P., Scherbaum W.A., Paschke R. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab. 82:1997;3885.
28. Kopp P., Jameson J.L., Roe T.F. Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid. 7:1997;765.
29. Kopp P., Muirhead S., Jourdain N., Gu W.X., Jameson J.L., Rodd C. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest. 100:1997;1634.
30. Duprez L., Hermanq J., Van Sande J., Dumont J.E., Vassart G., Parma J. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab. 82:1997;306.
31. Duprez L., Parma J., Castagliola S., Hermans J., Van Sande J., Dumont J.E., Vassart G. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett. 409:1997;469.
32. Tonacchera M., Vitti P., Agretti P., Giulianetti B., Mazzi B., Cavaliere R., Ceccarini G., Fiore E., Viacava P., Naccarato A., Pinchera A., Chiovato L. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid. 8:1998;559.
33. Duprez L., Parma J., Van Sande J., Allgeir A., Leclere J., Schwartz Delisle M.J., Decoulx M., Orgiazzi J., Dumont J., Vassart G. Germline mutations in the thyrotropin receptor gene cause non-autosomal dominant hyperthyroidism. Nat Genet. 7:1994;396.
34. Cotecchia S., Exum S., Caron M.G., Lefkowitz R.J. Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA. 87:1990;2896.
35. Wonerow P., Schöneberg T., Schultz G., Gudermann T., Paschke R. Deletions in the third intracellular loop of the thyrotropin receptor. a new mechanism for constitutive activation J Biol Chem. 273:1998;7900.
36. Krohn K., Emmrich P., Ott N., Paschke R. Increased thyroid epithelial cell proliferation in toxic thyroid nodules. Thyroid. 9:1999;214.
37. Leclere J., Bene M.C., Duprez A., Faure G., Thomas J.L., Vignaud M., Burlet C. Behaviour of thyroid tissue from patients with Graves' disease in nude mice. J Clin Endocrinol Metab. 59:1984;175.
38. Leclere J., Bene M.C., Aubert V., Klein M., Pascal-Vigneron V., Weryha G., Faure G. Clinical consequences of activating mutations of TSH receptor, the concept of toxic hyperplasia. Horm Res. 47:1997;158.